PT  - JOURNAL ARTICLE
AU  - Rachel M. Whitsel
AU  - Jaclyn A. Bjelac
AU  - Ahila Subramanian
AU  - Alice E. W. Hoyt
AU  - Sandra J. Hong
TI  - Oral immunotherapy: The answer to peanut allergy?
AID  - 10.3949/ccjm.88a.20130
DP  - 2021 Feb 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 104--109
VI  - 88
IP  - 2
4099  - http://www.ccjm.org/content/88/2/104.short
4100  - http://www.ccjm.org/content/88/2/104.full
SO  - Cleve Clin J Med2021 Feb 01; 88
AB  - Peanut and tree-nut allergies have increased dramatically in prevalence, especially in children. Historically, children with food allergies have been treated through strict avoidance of the allergen. Recently, an oral preparation of peanut allergen (Palforzia) was approved for immunotherapy (ie, desensitization) in children 4 to 17 years old. This article reviews oral immunotherapy and its role in children with peanut allergies.